معرفی
Professor Paul Chazot is a Professor in the Department of Biosciences at Durham University, with affiliations including the Wolfson Research Institute for Health and Wellbeing. His research focuses on identifying drug targets for CNS pathologies, developing novel behavioral tests, and advancing therapies like Photobiomodulation (PBM) for Alzheimer’s and chronic pain. He leads the spin-out company Nevrargenics, advancing RAR-M compounds for neurodegenerative diseases.
- Education: Not explicitly stated in text.
His research interests span histamine receptors, neurodegenerative diseases, pain mechanisms, and translational drug development. Notable contributions include clinical trials (Votucalis, PBM-T 1068nm) and roles in international organizations like the European Histamine Research Society (President, 2012–2018).
Recent publications highlight advancements in RARβ-modulators, neurotoxicity mechanisms, and AI applications in dementia diagnosis. Awards include Fellowships in the British Pharmacological Society and Durham Institute, reflecting his leadership in the field.
Supervision includes PhD students in neuroscience and pharmacology, with collaborations on projects like the UK Rugby Health Study. He directs the Pain Challenge Academy and mentors in Hatfield College.
